Generic Dacomitinib EGFR Inhibitor

This inhibitor, Dacomitinib, helps treat NSCLC by targeting certain mutations in the EGFR, like the deleted exon 19 or the L858R change in exon 21. It comes in three doses: 15, 30, or 45 milligrams. For adults, doctors usually recommend 45 milligrams, and you take it every day.

The pills have a covering and come in bottles with 30 tablets in each. It stops something called the EGFR signaling, which is a big deal in how NSCLC grows and gets worse, especially in people with those specific genetic changes.